Prognostic Implications of Baroreflex Sensitivity in Heart Failure Patients in the Beta-Blocking Era

Journal of the American College of Cardiology

Volumn 53, Issue 2, 2009, Pages 193-199

  La Rovere, Maria Teresa ^a   Pinna, Gian Domenico ^a   Maestri, Roberto ^a   Robbi, Elena ^a   Caporotondi, Angelo ^a   Guazzotti, Gianpaolo ^a   Sleight, Peter ^b   Febo, Oreste ^a  

^a IRCCS   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

autonomic nervous system; baroreceptors; beta blocker; heart failure; prognosis

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; CREATININE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; PHENYLEPHRINE; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BETA ADRENERGIC RECEPTOR BLOCKING; BILIRUBIN BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; SODIUM BLOOD LEVEL; SURVIVAL; UREA NITROGEN BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; AGED; BAROREFLEX; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 58149103177     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.09.034     Document Type: Article

References (20)

1. Eckberg D.L., Drabinsky M., and Braunwald E. Defective para-sympathetic control in patients with heart failure. N Engl J Med 285 (1971) 877-883
2. Zucker I.M. Neural mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48 (2006) 1005-1011
3. Osterziel K.J., Hanlein D., Willenbrock R., Eichhorn C., Luft E., and Dietz R. Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73 (1995) 517-522
4. Mortara A., La Rovere M.T., Pinna G.D., et al. Arterial baroreflex modulation of heart rate in chronic heart failure. Circulation 96 (1997) 3450-3458
5. Pinna G.D., Maestri R., Capomolla S., et al. Applicability and clinical relevance of the transfer function method in the assessment of baroreflex sensitivity in heart failure patients. J Am Coll Cardiol 46 (2005) 1314-1321
6. Clark A.L., and Cleland J.G.F. The control of adrenergic function in heart failure: therapeutic interventions. Heart Fail Rev 5 (2000) 101-114
7. Mortara A., La Rovere M.T., Pinna G.D., Maestri R., Capomolla S., and Cobelli F. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroreflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 36 (2000) 1612-1618
8. Kubo T., Parker J.D., Azevedo E.R., et al. Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover. Eur J Heart Fail 7 (2005) 878-881
9. La Rovere M.T., Pinna G.D., and Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol 13 (2008) 191-207
10. Floras J.S., Jones J.V., Hassan M.O., and Sleight P. Effects of acute and chronic beta-adrenoreceptor blockade on baroreflex sensitivity in humans. J Auton Nerv Syst 25 (1988) 87-94
11. Airaksinen K.E.J., Niemela M.J., and Huikuri H.V. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease. Eur Heart J 15 (1994) 1482-1485
12. Azevedo E.R., Kubo T., Mak S., et al. Nonselective versus selective β-adrenergic receptor blockade in congestive heart failure. Differential effects on sympathetic activity. Circulation 104 (2001) 2194-2199
13. Gourine A., Bondar S.I., Spyer K.M., and Gourine A.V. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart. Circ Res 102 (2008) 633-666
14. Kardos A., Watterich G., de Menezes R., Csanady M., Casadei B., and Rudas L. Determinants of spontaneous baroreflex sensitivity in a healthy working population. Hypertension 37 (2001) 911-916
15. Schrier R.W. Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006) 1-8
16. Melenowsky V., Simek J., Sperl M., Malik J., and Wichterle D. Relation between actual heart rate and autonomic effects of beta-blockade in healthy men. Am J Cardiol 95 (2005) 999-1002
17. Schwartz P.J., and La Rovere M.T. ATRAMI: a mark in the quest for the prognostic value of autonomic balance. Eur Heart J 19 (1998) 1593-1595
18. Conway J., Boon N., Jones J.V., and Sleight P. Involvement of the baroreceptor reflex in the changes in blood pressure with sleep and mental arousal. Hypertension 5 (1983) 746-748
19. Johansson M., Gao S.A., Friberg P., et al. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens 25 (2007) 163-168
20. Shin J., and Johnson J.A. β-blocker pharmacogenetics in heart failure. Heart Fail Rev (2008) Apr 24 [E-pub ahead of print]